CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for AME Company for Medical Supplies is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

AME Company for Medical Supplies
King Fahad Rd. 8088
AlFaisaliyah. Dist., 48352
JEDDAH, 23442  Saudi Arabia Ticker: 95279527

Business Summary
AME Company for Medical Supplies is a Saudi Arabia-based entity which is primarily engaged in medical supplies activities. The Company is concentrating in the aesthetic medicine market with a wide range of brands. The Company’s products include injectable hyaluronic acid-based dermal fillers, medical laser systems, autologous concentration system, Botulinum toxin type A, electronic equipment and dermo-cosmetic products, absorbable polydioxanone, etc.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202412/31/2023Yes----

General Information
Outstanding Shares: 7,000,000 (As of 6/30/2024)
Stock Exchange: SAU


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024